NCT00351884View on ClinicalTrials.gov

Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

November 30, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Vildagliptin AM

DRUG

vildagliptin pm

DRUG

placebo

Trial Locations (2)

07936

Novartis Pharmaceuticals, East Hanover

Unknown

Novartis Investigative Site, Investigative Centers

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY